Prior stroke and neurological disability increased long-term mortality after myocardial infarction. Learn how neurological status may guide risk assessment.

Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...

The proof of efficacy of thrombolysis for acute myocardial infarction (AMI) depends on 9 randomized placebo-controlled trials totaling 58,511 patients. The meta-analysis of these trials showed an ...

Acute myocardial infarction (AMI) continues to be a leading cause of death worldwide, necessitating rapid and accurate diagnosis to mitigate severe cardiac damage. The electrocardiogram (ECG) remains ...

Although the use of primary angioplasty in the acute myocardial infarction (AMI) setting has been shown to achieve TIMI 3 flow in the majority of patients, there are still some instances in which ...

This subanalysis of data from the VIRGO study encompassed 2979 patients who had an acute myocardial infarction (AMI), or heart attack, between ages 18 and 55 years; outcomes evaluated included ...

Despite a previous decline, AMI mortality rates are increasing among individuals with nicotine dependence in the US. Recent increases in acute myocardial infarction (AMI) mortality rates with nicotine ...

Patients with preexisting gastroesophageal reflux disease (GERD) have an increased risk for incident acute myocardial infarction (AMI), according to a study published online Oct. 13 in JGH Open.

Deepak Bhatt, MD, Mount Sinai Heart, highlights the kidney-specific outcomes of the pivotal EMPACT-MI clinical trial in an interview at the 2024 European Society of Cardiology Congress. At the 2024 ...